Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Premiums ‘Won’t Go Up’ With HHS Rebate Proposal, Azar Maintains

Executive Summary

US HHS secretary tells Senate Finance Committee he believes pharmacy benefit managers will effectively keep drug costs down in Medicare Part D, even without rebates.

You may also be interested in...



One More Score: CBO Projects HHS Rebate Proposal Would Boost Part D Spending $170bn

HHS downplays latest attempt to predict “complex behavior changes to a broken system.”

Running The Gauntlet: Takeaways From The First Round Of HHS Hearings In 2019

Release of the White House budget proposal kicked off the first round of hearings on HHS with a new Democratic majority in the House and a new HHS budget czar in the Senate. HHS Secretary Azar did his best to set a constructive tone for advancing drug pricing policies – and maintaining his own position – in the year to come.  

Rebates Would Be Eliminated In Commercial Market Under Senate Bill

Legislation by Sen. Mike Braun, R-Ind., would apply to the private insurance market changes proposed by the HHS Office of Inspector General for Medicare and Medicaid managed care plans.

Related Content

Topics

UsernamePublicRestriction

Register

PS124931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel